Sideinnhold
A -
B -
C -
D -
E -
F -
G -
H -
I -
J -
K -
L -
M -
N -
O -
P -
Q -
R -
S -
T -
U -
V -
X -
Y -
Z
(S) = sykehuslegemiddel
| Ravicti (S) | glyserolfenylbutyrat | Ureasyklusdefekter | 2018 |
|---|
| Reagila | kariprazin | Schizofreni | 2019
|
|---|
Reblozyl (S)
| luspatercept
| Anemi
| 2021
|
|---|
| Refixia (S) | nonacog beta pegol | Hemofili B | 2018 |
|---|
| metylnaltrekson
| Opioidindusert forstoppelse | 2011 |
|---|
Relvar
| flutikason, vilanterol
| Astma, KOLS
| 2020
|
|---|
Repatha
| evolokumab | Hyperkolesterolemi | 2016
|
|---|
Repatha
| evolokumab
| Hyperkolesterolemi
| 2019
|
|---|
Resolor
| prukaloprid | Kronisk forstoppelse | 2012
|
|---|
Retsevmo (S)
| selperkatinib
| Ikke-småcellet lungekreft
| 2022
|
|---|
| lenalidomid | Myelomatose (1)
| 2009 |
|---|
| lenalidomid | Myelomatose (2)
| 2010 |
|---|
Revlimid (S)
| lenalidomid | Myelomatose (3)
| 2018 |
|---|
| Revlimid (S) | lenalidomid | Myelomatose (4)
| 2018 |
|---|
| Revolade | eltrombopag | ITP, aplastisk anemi | 2018 |
|---|
| Rinvoq (S) | upadacitinib | Revmatoid artritt | 2020 |
|---|
| Rinvoq (S) | upadacitinib | Psoriasisartritt | 2021 |
|---|
| Rinvoq (S) | upadacitinib | Ankyloserende spondylitt
| 2021
|
|---|
Rinvoq (S)
| upadacitinib
| Atopisk eksem
| 2021
|
|---|
| metylfenidat | ADHD | 2006 |
|---|
| Ritalin depotkapsel | metylfenidat | ADHD voksne | 2014 |
|---|
| Rixubis (S) | nonacog gamma | Hemofili B | 2016 |
|---|
RoActemra (S)
Oppdatert metodevurdering
| tocilizumab | kjempecellearteritt | 2018
2022
|
|---|
Rozlytrek (S)
| entrektinib
| NTRK-fusjonspositive solide svulster
| 2021
|
|---|
Rozlytrek (S)
| entrektinib
| Ikke-småcellet lungekreft subgruppe
| 2020
|
|---|
| Rukobia (S) | fostemsavir | HIV-1
| 2021
|
|---|
Ryeqo
| relugoliks/østradiol/noretisteron | Myomer
| 2022
|
|---|
| Rxulti | brekspiprazol | schizofreni | 2019
|
|---|
Rybelsus
| semaglutid
| Diabetes mellitus, type II
| 2021
|
|---|
| Rydapt (S) | midostaurin | AML | 2019 |
|---|
| Rydapt (S) | midostaurin | mastocytose (ASM) | 2019 |
|---|
